Navigation Links
Marshall Edwards Announces Private Placement
Date:5/2/2011

idase inhibitor program that includes lead drug candidate NV-143. The second is a mitochondrial inhibitor program that includes NV-128 and its next-generation candidate NV-344. Both programs are expected to advance into the clinic in 2011. For more information, please visit www.marshalledwardsinc.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; government regulation; ch
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
2. Marshall Edwards Receives Positive Response From NASDAQ
3. Marshall Edwards to Host Annual Meeting of Stockholders
4. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
5. Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells
6. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
7. Edwards Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
8. Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film
9. Esperion Announces Results From Phase 1 Study and Four Preclinical Studies for ETC-1002
10. Regeneron Announces Presentation at the Bank of America Merrill Lynch 2011 Health Care Conference
11. Amira Pharmaceuticals Announces Completion of Phase 1 Clinical Study for AM152, A Novel LPA1 Receptor Antagonist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... The potential of the pulmonary route as ... has been receiving undeniable attention with the recent advances ... crucial formulation considerations for orally inhaled products together with ... in the efficiency of pulmonary delivery, and great strides ... techniques and devices in recent years. With ...
(Date:5/23/2013)... Inc. (Vanda) (NASDAQ: VNDA ) today announced that ... of the Year by the Tech Council of ... 25 th Annual Tech Awards Celebration held in ... the leaders and innovators in the technology and life science ... regions. "We are deeply honored to receive ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... th Annual  Healthcare Conference on Thursday, May 30, 2013, ... , beginning at 9:20 a.m. Eastern Daylight Time. ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... (AMEX: ISR ), a medical technology company ... for brain cancer, lung cancer, head and neck cancer ... and Chief Executive Officer, will co-present at RetailInvestorConferences.com. ... PM EST LINK:   www.retailinvestorconferences.com > ...
...   Leatt Corporation (OTC: LEAT.PK), a global marketer ... designed to help prevent potentially devastating injuries to the ... formation of an agreement with Whites Powersports for the ... Whites Powersports has more than 50 years experience in ...
Cached Medicine Technology:IsoRay, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st 2Leatt Announces Distribution Agreement With Whites Powersports for New Zealand Market 2
(Date:5/25/2013)... May 25, 2013 By working diligently ... declared the integration of the 2012 Lamborghini Aventador into ... the latest entrant in the list of vehicles lined ... vehicle is all set to thrill automobile lovers in ... power and spectacular looks, the 2012 Lamborghini Aventador comes ...
(Date:5/25/2013)... According to world-renowned scholars, Queen Cleopatra ... women that ever lived. Cleopatra’s legendary beauty moved nations ... most powerful men in her time. Cleopatra was also ... her skin glowing and fresh, from her legendary milk ... oil and cyprus grass. , Cleopatra was said to ...
(Date:5/25/2013)... 25, 2013 For college students, ... week. Increasingly, they are turning to prescription stimulants ... study. For more on this, go to ... facility, warns that students who pick up Adderall, ... risk for developing a physical and psychological dependency. ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 HealthCrave ... that is unique in that it doesn’t just ... focuses on treating what causes the noticeable signs ... physician Dr. James D. Weiss, M.D., the center ... aging process while helping patients to live longer, ...
(Date:5/24/2013)... A recent study by research group Harris Interactive found that ... season. Almost 138 million people are fearful of pulling on ... issues and a quarter admit they feel pressured to lose ... those anxious about their size consider the over the counter ... effort to improve diet and exercise habits ahead of peak ...
Breaking Medicine News(10 mins):Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Anti-Aging Center Offers Advanced Treatment that Controls the Aging Process from Within 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3
... HealthDay Reporter , MONDAY, Sept. 26 (HealthDay News) ... brain size and more problems with thinking skills as people ... who suffer from B-12 deficiencies may be greater than thought ... not be accurate, said Christine C. Tangney, lead author of ...
... study shows that 145,000 deaths could be averted in ... stronger tobacco control policies. This set of policies, as ... Organisation, consists of increasing tobacco taxes to 70% of ... public places, a complete marketing ban, well-funded tobacco control ...
... cancer patients who use a new combination of the ... Gy) before surgery have an 88 percent chance of ... randomized trial presented at the plenary session, October 3, ... Society for Radiation Oncology (ASTRO). "The results of ...
... 26, 2011 Notable levels of calcium buildup in coronary ... in people with diabetes and metabolic syndrome, according to a ... The researchers also found that individuals with diabetes or metabolic ... as low as many without these conditions. Supported by ...
... treatment for one form of albinism? Individuals ... pale skin, and light-colored irises because they have none, or ... and eyes. Affected individuals have impaired eyesight and a substantially ... to attempts to correct eyesight and counseling to promote the ...
... health challenges earlier than their fellow seniors, researchers ... lives of 8,700 older people, a Case Western ... reported physical limitations by African American women in ... finding surfaced as researchers looked generally at how ...
Cached Medicine News:Health News:Could Too Little Vitamin B-12 Shrink the Aging Brain? 2Health News:Could Too Little Vitamin B-12 Shrink the Aging Brain? 3Health News:Stronger tobacco control policy in the Netherlands would save thousands of lives 2Health News:Chemo plus radiation before surgery increases tumor response for rectal cancer 2Health News:JCI online early table of contents: September 26, 2011 2Health News:JCI online early table of contents: September 26, 2011 3Health News:JCI online early table of contents: September 26, 2011 4Health News:JCI online early table of contents: September 26, 2011 5Health News:JCI online early table of contents: September 26, 2011 6Health News:JCI online early table of contents: September 26, 2011 7Health News:African-American women develop functional challenges earlier than others 2Health News:African-American women develop functional challenges earlier than others 3
The AutoSet Respond offers ResMeds unique AutoSet algorithm and product quality in a convenient, affordable model. The AutoSet algorithm responds to the patients pressure needs on a breath-by-breath ...
These products are primarily for use with paediatric patients and for patients with difficult veins....
... helps protect you against needlestick injury. Its ... exposure to a contaminated needle, provides easy ... for use in high-risk environments. The one-handed ... for activation of the safety mechanism while ...
... System provides the capability to ... middle of surgery while retaining ... incision. The system is also ... for large patients while remaining ...
Medicine Products: